<bill session="115" type="s" number="2067" updated="2019-04-18T16:40:04Z">
  <state datetime="2017-11-02">REFERRED</state>
  <status>
    <introduced datetime="2017-11-02"/>
  </status>
  <introduced datetime="2017-11-02"/>
  <titles>
    <title type="official" as="introduced">A bill to amend title XVIII of the Social Security Act to provide for coverage under the Medicare program of certain DNA Specimen Provenance Assay clinical diagnostic laboratory tests.</title>
    <title type="short" as="introduced">Prostate Cancer Misdiagnosis Elimination Act of 2017</title>
    <title type="short" as="introduced">Prostate Cancer Misdiagnosis Elimination Act of 2017</title>
    <title type="display">Prostate Cancer Misdiagnosis Elimination Act of 2017</title>
  </titles>
  <sponsor bioguide_id="C000880"/>
  <cosponsors/>
  <actions>
    <action datetime="2017-11-02">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2017-11-02" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="115" relation="unknown" number="2557"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2017-11-02T04:00:00Z" status="Introduced in Senate">Prostate Cancer Misdiagnosis Elimination Act of 2017 This bill provides&#160;for Medicare&#160;coverage of&#160;a DNA Specimen Provenance Assay clinical diagnostic laboratory test&#160;following a positive prostate cancer biopsy.</summary>
  <committee-reports/>
</bill>
